Eliquis 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FWUF7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,295
Award facts
- Contract value 100% obligated
- $11,294.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,294.68 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) under a firm fixed-price contract. The award was made on April 23, 2025, with an ultimate completion date of April 24, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in that same city. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying an extensive portfolio of brand-name and generic medications to military and veteran healthcare systems. The company's substantial IDC with DLA enables it to fulfill diverse medical supply needs across multiple therapeutic domains for organizations including the Defense Health Agency and U.S. Coast Guard. This particular delivery order for Eliquis, an anticoagulant medication, exemplifies the routine pharmaceutical fulfillment operations conducted through the prime vendor contract, which supports military healthcare programs globally and is positioned for potential expansion through DLA's planned Pharmaceutical Prime Vendor Global Program Generation V initiative.
Quick answers
Who was awarded contract SPE2DB25FWUF7?
SPE2DB25FWUF7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 23, 2025.
How much is contract SPE2DB25FWUF7 worth?
The government has obligated $11,295 on SPE2DB25FWUF7.
Is contract SPE2DB25FWUF7 an order under another contract?
Yes. SPE2DB25FWUF7 is a delivery order under SPE2DB24D2018, an indefinite delivery contract.
Was contract SPE2DB25FWUF7 competed?
The extent of competition for SPE2DB25FWUF7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award